Glenvastatin

Glenvastatin

SCHEMBL9872411

CC(C)c1nc(-c2ccccc2)cc(-c2ccc(F)cc2)c1/C=C/[C@H]1C[C@H](O)CC(=O)O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HMGCR P04035 12/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9022892 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL1040745 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL49508 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL10024037 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL1660022 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL1040744 1.00 HMGCR (1.00) HMGCR
Glenvastatin SCHEMBL29557142 1.00 HMGCR (1.00) HMGCR
SCHEMBL9527887 0.96 HMGCR (1.00) HMGCR
SCHEMBL9022328 0.94 HMGCR (0.89) HMGCR
SCHEMBL9022402 0.92 HMGCR (0.85) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4997837-A Enzyme inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-05 — — US disclosed
US-4906624-A 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis WARNER-LAMBERT COMPANY (US) 1990-03-06 — — US disclosed
EP-0306929-A2 6-[[(Substituted)pyridin-3-YL]alkyl]-and alkenyl]-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis WARNER-LAMBERT COMPANY (US) 1989-03-15 — — EP disclosed
Send feedback